Proteolysis Targeting Chimera Degraders of the METTL3–14 m<sup>6</sup>A-RNA Methyltransferase-Reference-Cited by-同舟云学术

Proteolysis Targeting Chimera Degraders of the METTL3–14 m⁶A-RNA Methyltransferase

Published:2024-02-12 Issue:2 Volume:4 Page:713-729
ISSN:2691-3704
Container-title:JACS Au
language:en
Short-container-title:JACS Au

Author:

Errani Francesco¹^ORCID,Invernizzi Annalisa¹^ORCID,Herok Marcin¹,Bochenkova Elena¹,Stamm Fiona¹,Corbeski Ivan¹,Romanucci Valeria²^ORCID,Di Fabio Giovanni²^ORCID,Zálešák František¹,Caflisch Amedeo¹^ORCID

Affiliation:

1. Department of Biochemistry, University of Zurich, Winterthurerstrasse 190, Zurich CH-8057, Switzerland

2. Università degli Studi di Napoli Federico II, Via Cintia 4, Napoli I-80126, Italia

Funder

Schweizerischer Nationalfonds zur F?rderung der Wissenschaftlichen Forschung

Swiss Cancer Research Foundation

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/jacsau.4c00040

Reference73 articles.

1. Deciphering Epitranscriptome: Modification of mRNA Bases Provides a New Perspective for Post-transcriptional Regulation of Gene Expression

2. m 6 A in mRNA: An Ancient Mechanism for Fine-Tuning Gene Expression

3. MODOMICS: a database of RNA modification pathways. 2021 update

4. Dominissini, D.; Moshitch-Moshkovitz, S.; Schwartz, S.; Salmon-Divon, M.; Ungar, L.; Osenberg, S.; Cesarkas, K.; Jacob-Hirsch, J.; Amariglio, N.; Kupiec, M.; Sorek, R.; Rechavi, G. Topology of the Human and Mouse m6A RNA Methylomes Revealed by m6A-Seq. 2012, 485 (7397), 201–206. 10.1038/nature11112.

5. HNRNPA2B1 Is a Mediator of m6A-Dependent Nuclear RNA Processing Events

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Degradation of METTL3 Against Acute Myeloid Leukemia and Gastric Cancer.;European Journal of Medicinal Chemistry;2024-09

2. Therapeutic strategies to target the epitranscriptomic machinery;Current Opinion in Genetics & Development;2024-08

3. Small molecule inhibitors targeting m6A regulators;Journal of Hematology & Oncology;2024-05-06